Jenny Ahlstrom

Jenny Ahlstrom

Founder and CEO of HealthTree

Latest Stories
Guest Editorial
Today’s traditional research model relies on incremental innovation that builds upon the shoulders of other researchers’ work, making small but steady strides. Occasionally, leaps are made by researchers who develop new classes of therapy such as stem cell transplant or CAR-T immunotherapy. But cancer patients may not have the luxury to wait 20 years for the traditional scientific process to evolve for their cancer. They can’t wait for a cure.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login